Larry Radican

Summary

Affiliation: Merck Research Laboratories
Country: USA

Publications

  1. ncbi Pre-existing cardiovascular diseases and glycemic control in patients with type 2 diabetes mellitus in Europe: a matched cohort study
    Alex Z Fu
    Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA
    Cardiovasc Diabetol 9:15. 2010
  2. ncbi A retrospective occupational cohort study of end-stage renal disease in aircraft workers exposed to trichloroethylene and other hydrocarbons
    Larry Radican
    Worldwide Outcomes Research, Merck and Co, Inc, Whitehouse Station, NJ 08889, USA
    J Occup Environ Med 48:1-12. 2006
  3. ncbi Mortality of aircraft maintenance workers exposed to trichloroethylene and other hydrocarbons and chemicals: extended follow-up
    Larry Radican
    Global Outcomes Research Department, Merck and Co, Inc, NJ 08889, USA
    J Occup Environ Med 50:1306-19. 2008
  4. ncbi Differences in baseline characteristics between patients prescribed sitagliptin versus exenatide based on a US electronic medical record database
    Qiaoyi Zhang
    Global Health Outcomes, Merck Sharp and Dohme Corp, One Merck Drive, Whitehouse Station, NJ 08889 0100, USA
    Adv Ther 27:223-32. 2010
  5. ncbi Baseline characteristic differences between patients prescribed sitagliptin vs. other oral antihyperglycemic agents: analysis of a US electronic medical record database
    Qiaoyi Zhang
    Merck Sharp and Dohme Corp, Global Health Outcomes, Whitehouse Station, NJ 08889 0100, USA
    Curr Med Res Opin 26:1697-703. 2010
  6. ncbi Assessment of severity and frequency of self-reported hypoglycemia on quality of life in patients with type 2 diabetes treated with oral antihyperglycemic agents: A survey study
    Elizabeth Marrett
    Global Health Outcomes, Merck Sharp and Dohme, Corp, Whitehouse Station, NJ, USA
    BMC Res Notes 4:251. 2011

Collaborators

Detail Information

Publications6

  1. ncbi Pre-existing cardiovascular diseases and glycemic control in patients with type 2 diabetes mellitus in Europe: a matched cohort study
    Alex Z Fu
    Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA
    Cardiovasc Diabetol 9:15. 2010
    ..Our aim was to examine the degree of glycemic control among T2DM patients in Europe with and without pre-existing CVD...
  2. ncbi A retrospective occupational cohort study of end-stage renal disease in aircraft workers exposed to trichloroethylene and other hydrocarbons
    Larry Radican
    Worldwide Outcomes Research, Merck and Co, Inc, Whitehouse Station, NJ 08889, USA
    J Occup Environ Med 48:1-12. 2006
    ..Case-control studies suggest hydrocarbons increase end-stage renal disease (ESRD) risk. No cohort studies have been conducted...
  3. ncbi Mortality of aircraft maintenance workers exposed to trichloroethylene and other hydrocarbons and chemicals: extended follow-up
    Larry Radican
    Global Outcomes Research Department, Merck and Co, Inc, NJ 08889, USA
    J Occup Environ Med 50:1306-19. 2008
    ..To extend follow-up of 14,455 workers from 1990 to 2000, and evaluate mortality risk from exposure to trichloroethylene (TCE) and other chemicals...
  4. ncbi Differences in baseline characteristics between patients prescribed sitagliptin versus exenatide based on a US electronic medical record database
    Qiaoyi Zhang
    Global Health Outcomes, Merck Sharp and Dohme Corp, One Merck Drive, Whitehouse Station, NJ 08889 0100, USA
    Adv Ther 27:223-32. 2010
    ..This study examined differences in baseline characteristics between patients with type 2 diabetes initiating sitagliptin vs. exenatide treatment in clinical practice settings in the US...
  5. ncbi Baseline characteristic differences between patients prescribed sitagliptin vs. other oral antihyperglycemic agents: analysis of a US electronic medical record database
    Qiaoyi Zhang
    Merck Sharp and Dohme Corp, Global Health Outcomes, Whitehouse Station, NJ 08889 0100, USA
    Curr Med Res Opin 26:1697-703. 2010
    ....
  6. ncbi Assessment of severity and frequency of self-reported hypoglycemia on quality of life in patients with type 2 diabetes treated with oral antihyperglycemic agents: A survey study
    Elizabeth Marrett
    Global Health Outcomes, Merck Sharp and Dohme, Corp, Whitehouse Station, NJ, USA
    BMC Res Notes 4:251. 2011
    ..abstract:..